Menu
Recruiting NCT07026890

The Benefits of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome

No phase Interventional Psychomotor Disadaptation Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Evaluation visits, Rehabilitation sessions, Virtual reality sessions, Additional rehabilitation sessions.
Who it may be relevant to
Registry conditions: Psychomotor Disadaptation Syndrome. Basic parameters: from 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Value of Virtual Reality in the Care of Elderly People With Psychomotor Disadaptation Syndrome: a Randomised Controlled Trial of Mixed Efficacy and Implementation vs. Conventional Rehabilitative Care

Overview

Psychomotor Disadaptation Syndrome (PMDS) is characterised by a deterioration in postural function, gait and psychomotor automatisms in the elderly. It is often associated with falls and can manifest itself as retropulsion, gait abnormalities, neurological disorders and psycho-behavioural problems. For the majority of these patients, a stay in a geriatric medical and rehabilitation centre is necessary, enabling an objective assessment of these disorders and multi-professional care, including physiotherapists, occupational therapists and adapted physical activity teachers, aimed at restoring safe movement and motor independence. However, rehabilitation relies on traditional exercises that are limited, repetitive and sometimes far removed from everyday activities. Technological innovations such as virtual reality (VR) offer opportunities to improve care by creating immersive environments that reproduce real-life situations. VR could thus help to rehabilitate the motor problems associated with MS. The aim of the VIR-AGE project is to study the clinical benefits of VR in the rehabilitation of hospitalised elderly people suffering from PMDS in terms of functional deficits, particularly motor deficits. The study will take place at the Centre gériatrique Champmaillot of the CHU Dijon Bourgogne. A total of 50 patients with SPDM will take part. The total duration of your participation is 5 weeks.

Interventions

  • Other Evaluation visits
    3 assessment visits (initial (V1), intermediate (V2) and final (V3). A series of motor assessments carried out by the physiotherapist: * Timed Up and Go Test (TUG) * 10 m walk test (TM10) * Functional Reach Test (FRT) * Minimum Motor Test (TMM) * 10 m walk test combined with a verbal task such as naming different animals
  • Other Rehabilitation sessions
    Usual treatment: 4 to 5 rehabilitation sessions per week, each lasting 45 minutes.
  • Other Virtual reality sessions
    3 virtual reality sessions per week, each lasting 30 minutes.
  • Other Additional rehabilitation sessions
    3 additional rehabilitation sessions per week. These sessions correspond to standard rehabilitation sessions.

Primary outcome measures

  • Change in 'Timed Up and Go' time between initial and final assessment [Time frame: 5 weeks]

Eligibility criteria

Inclusion criteria

  • Person who has given written consent
  • Person aged ≥ 65 years;
  • With a proven diagnosis of motor maladjustment syndrome;
  • Hospitalised in a geriatric care unit;
  • Able to understand a simple instruction and answer a closed question;
  • Ability to perform the TUG within 7 days of arriving on site

Exclusion criteria

  • Person not affiliated to or not benefiting from a social security scheme
  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a judicial protection measure
  • An adult who is incapable or unable to give consent
  • Persons with epilepsy, kinetosis or known claustrophobia Persons unable to understand simple instructions for carrying out tests
  • Anyone with a severe visual and/or hearing impairment
  • Any person with a behavioural disorder (agitation, aggressiveness)
  • Any person with a severe walking or balance problem that makes motor exercises unsuitable
  • Anyone with a pathology, injury, wound or severe deformity to the head or cervical spine
  • Any person suffering from severe vertigo, diagnosed at the discretion of the investigating doctor
  • Inability to use arm for pointing
  • Persons susceptible to migraines
  • Non-French speakers
  • Anyone with an inter-pupillary distance outside the range of possible helmet adjustments

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Other

Study locations

France · 1 center
  • CHU Dijon Bourgogne — Dijon

Identifiers

NCT: NCT07026890 · DIPANDA 2024

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗